Phathom Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Florham Park, NJ
PHAT chart
What traders are saying about $PHAT
Latest postsPhathom Pharmaceuticals, Inc. news
- Hoa Phat stock gains outlook as steel earnings beat 2026 plan
ad-hoc-news.de ·
- Clients hold the 30,562 shares Invesco reports in Phathom Pharmaceuticals (PHAT).
Stock Titan ·
- PHAT: GI-led growth and improving access support a path to broader primary-care and OTC opportunities
TradingView ·
- Phathom Pharmaceuticals, Inc. (PHAT) stock price, news, quote and history
Yahoo Finance UK ·
- Implied Volatility Surging for Phathom Pharmaceuticals Stock Options
Yahoo Finance ·
- PHAT: Prescription Gains Support The Bull Case, Exclusivity Risk Now Sets The Limits
Simply Wall St ·
- What Phathom Pharmaceuticals Bears Spotted Before A 63% Slide
Yahoo Finance ·
- Phathom Pharmaceuticals to Participate in November Investor Conferences
Yahoo Finance ·
- Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx
Yahoo Finance ·
- What Phathom Pharmaceuticals (PHAT) Said on Its Q3 Earnings Call
marketbeat.com ·
- Phathom Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Phathom (PHAT) Q3 2026 Earnings Call Transcript
fool.com ·
Phathom Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $175.1M | $55.3M | $682,000 | $0 |
| Net income | -$221,250 | -$334,330 | -$201,590 | -$197.7M |
| Diluted EPS | $-3.03 | $-5.29 | $-3.93 | $-5.05 |
| Total assets (year end) | $259.1M | $378.3M | $413.8M | $164.8M |
| Cash and equivalents (year end) | $130.0M | $297.3M | $381.4M | $155.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Phathom Pharmaceuticals, Inc.
- Ticker
- PHAT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Florham Park, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1783183
Frequently asked questions
What exchange is Phathom Pharmaceuticals, Inc. listed on?
Phathom Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol PHAT.
What industry is Phathom Pharmaceuticals, Inc. in?
Phathom Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Phathom Pharmaceuticals, Inc. headquartered?
Phathom Pharmaceuticals, Inc.'s business address on file with the SEC is in Florham Park, NJ.
When does Phathom Pharmaceuticals, Inc.'s fiscal year end?
Phathom Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Phathom Pharmaceuticals, Inc. report?
Phathom Pharmaceuticals, Inc. reported $175.1M in revenue for calendar year 2025, according to its SEC filings.